home / stock / bfra / bfra news

BFRA News and Press, Biofrontera AG From 05/29/19

Stock Information
Company Name: Biofrontera AG
Stock Symbol: BFRA
Market: NASDAQ
Menu
BFRA BFRA Quote BFRA Short BFRA News BFRA Articles BFRA Message Board
Get BFRA Alerts

News, Short Squeeze, Breakout and More Instantly...
BFRA - Biofrontera Reports First Quarter 2019 Financial Results

Leverkusen, Germany, May 29, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the first quarter ended March 31, 2019 and provided an updat...
BFRA - Biofrontera Announces Conference Call on May 29, 2019 to Discuss First Quarter 2019 Financial Results

Leverkusen, Germany, May 16, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its financial results for the first quarter ended March 31, 2019 on May 29, 2019. ...

BFRA - Biofrontera AG (BFRA) CEO Hermann Lübbert on Q4 2018 Results - Earnings Call Transcript

Biofrontera AG (BFRA) Q4 2018 Results Conference Call April 29, 2019 08:30 AM ET Company Participants Pamela Keck - IR Hermann Lübbert - CEO Thomas Schaffer - CFO Christoph Dünwald - CCO Conference Call Participants Bruce Jackson - The Benchmark Company Thomas...

BFRA - Biofrontera Reports Full Year 2018 Financial Results

Leverkusen, Germany, April 29, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the full year ended December 31, 2018 and provided an upda...
BFRA - Biofrontera AG to hold extraordinary shareholders' meeting on 15 May 2019

Leverkusen, Germany, April 26, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced in the Federal Gazette that it will hold an extraordinary shareholders' meeting on ...

BFRA - Biofrontera reports further positive results from the phase III trial with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neck

Leverkusen, Germany, April 16, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports positive results for the secondary endpoints of its Phase III clinical trial evaluati...

BFRA - Biofrontera Announces Conference Call on April 29, 2019 to Discuss 2018 Financial Results

Leverkusen, Germany, April 16, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its financial results for the full financial year ended December 31, 2018 on Apri...
BFRA - Biofrontera reports preliminary unaudited sales revenue for the first three months of 2019

Leverkusen, Germany, April 15, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports preliminary unaudited revenue for the first three months of fiscal year 2019. The ...

BFRA - Biofrontera provides information on the announced voluntary public tender offer by Maruho Deutschland GmbH

Leverkusen, Germany, April 02, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, informs about the announced voluntary public tender offer by Maruho Deutschland GmbH. Maruho Deu...

BFRA - Changes in the composition of the Supervisory Board

Leverkusen, Germany, March 27, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces that the Cologne Local District Court ( Amtsgericht ) dismissed Mr. Hansjörg Plaggem...
Previous 10 Next 10